CD4 and cancer: Professional APCs possess all the machinery to optimally process and present antigens to T cells, while malignant tumor cells lack some of the processing machinery needed to generate the large repertoire of functional HLA peptide complexes necessary for a robust CD4+ T cell response [15,50,66].